Press Releases and News

RedShift BioAnalytics Appoints Amol Chaubal, CFO of Waters Corporation, to Board of Directors

September 7, 2021

Burlington, MA- Sept 7th,  2021 RedShift BioAnalytics (RedShiftBio), a company providing next-generation platform technology enabling measurements of previously undetectable structure changes in biomolecules, announced the appointment of Amol Chaubal to its Board of Directors. Chaubal is Chief Financial Officer at Waters Corporation, the world’s leading specialty measurement company, which has pioneered chromatography, mass spectrometry, and … “RedShift BioAnalytics Appoints Amol Chaubal, CFO of Waters Corporation, to Board of Directors”

READ MORE

Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics

April 16, 2020

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, today announced that the combination of PBI’s patented Pressure Cycling Technology (“PCT”) with RedShiftBio’s proprietary Microfluidic Modulation Spectroscopy (“MMS”) resulted in a powerful new platform for biotherapeutic drug development (“PCT-enhanced MMS”).

READ MORE

The AQS³pro – A Hit For The Second Year Running at PEGS Europe

December 2, 2019

Lisbon Portugal hosted the European PEGS conference. This is the largest European event covering all aspects of protein and antibody engineering. Over 1300 attendees gathered to learn about the latest advances in protein and antibody engineering. This was the second year we showcased the next generation IR-based AQS3pro for secondary structure characterization. During this conference … “The AQS³pro – A Hit For The Second Year Running at PEGS Europe”

READ MORE

Accelerating Novel And Complex Modules Towards CMC Success

November 21, 2019

The 2020 Well Characterized Biologics and Biological Assays conference has just concluded. The agenda focused on practical advice for ensuring CMC success using characterization strategies. Most attendees we spoke with were interested in exploring alternative technologies to circular dichroism and FTIR for monitoring protein structure changes. We demonstrated the power of IR-based Microfluidic Modulation Spectroscopy … “Accelerating Novel And Complex Modules Towards CMC Success”

READ MORE